A Clue to the Vagaries of the Dopamine Receptor | GenomeWeb

Scientific American offers an article on recent research from Ohio State University that may turn out to be a biomarker that could help physicians prescribe the best antipsychotic drug for a patient with a mental illness. The research team found SNPs and other variation in the gene that codes for a receptor for dopamine, which could help explain why patients have long shown very different reactions to antipsychotic drugs.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.